Kyra van der Pan,Sandra de Bruin-Versteeg,Daniela Damasceno,Alejandro Hernández-Delgado,Alita J. van der Sluijs-Gelling,Wouter B. L. van den Bossche,Inge F. de Laat,Paula Díez,Brigitta A. E. Naber,Annieck M. Diks,Magdalena A. Berkowska,Bas de Mooij,Rick J. Groenland,Fenna J. de Bie,Indu Khatri,Sara Kassem,Anniek L. de Jager,Alesha Louis,Julia Almeida,Jacqueline A. M. van Gaans-van den Brink,Alex-Mikael Barkoff,Qiushui He,Gerben Ferwerda,Pauline Versteegen,Guy A. M. Berbers,Alberto Orfao,Jacques J. M. van Dongen,Cristina Teodosio

Abstract:Innate myeloid cell (IMC) populations form an essential part of innate immunity. Flow cytometric (FCM) monitoring of IMCs in peripheral blood (PB) has great clinical potential for disease monitoring due to their role in maintenance of tissue homeostasis and ability to sense micro-environmental changes, such as inflammatory processes and tissue damage. However, the lack of standardized and validated approaches has hampered broad clinical implementation. For accurate identification and separation of IMC populations, 62 antibodies against 44 different proteins were evaluated. In multiple rounds of EuroFlow-based design-testing-evaluation-redesign, finally 16 antibodies were selected for their non-redundancy and separation power. Accordingly, two antibody combinations were designed for fast, sensitive, and reproducible FCM monitoring of IMC populations in PB in clinical settings (11-color; 13 antibodies) and translational research (14-color; 16 antibodies). Performance of pre-analytical and analytical variables among different instruments, together with optimized post-analytical data analysis and reference values were assessed. Overall, 265 blood samples were used for design and validation of the antibody combinations and in vitro functional assays, as well as for assessing the impact of sample preparation procedures and conditions. The two (11- and 14-color) antibody combinations allowed for robust and sensitive detection of 19 and 23 IMC populations, respectively. Highly reproducible identification and enumeration of IMC populations was achieved, independently of anticoagulant, type of FCM instrument and center, particularly when database/software-guided automated ( vs. manual “expert-based”) gating was used. Whereas no significant changes were observed in identification of IMC populations for up to 24h delayed sample processing, a significant impact was observed in their absolute counts after >12h delay. Therefore, accurate identification and quantitation of IMC populations requires sample processing on the same day. Significantly different counts were observed in PB for multiple IMC populations according to age and sex. Consequently, PB samples from 116 healthy donors (8-69 years) were used for collecting age and sex related reference values for all IMC populations. In summary, the two antibody combinations and FCM approach allow for rapid, standardized, automated and reproducible identification of 19 and 23 IMC populations in PB, suited for monitoring of innate immune responses in clinical and translational research settings.

High-Content Immunophenotyping and Hierarchical Clustering Reveal Sources of Heterogeneity and New Surface Markers of Human Blood Monocyte Subsets

Comprehensive analysis of human monocyte subsets using full-spectrum flow cytometry and hierarchical marker clustering

Design of a Robust Flow Cytometric Approach for Phenotypical and Functional Analysis of Human Monocyte Subsets in Health and Disease

Identification of Novel Human Monocyte Subsets and Evidence for Phenotypic Groups Defined by Interindividual Variations of Expression of Adhesion Molecules

Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases

Monocyte Single-Cell Multimodal Profiling in Cardiovascular Disease Risk States

An Unbiased Flow Cytometry-Based Approach to Assess Subset-Specific Circulating Monocyte Activation and Cytokine Profile in Whole Blood

Clinical significance of monocyte heterogeneity

Blood Monocytes and Their Subsets: Established Features and Open Questions

Single-cell multimodal profiling of monocytes reveals diverse phenotypes and alterations linked to cardiovascular disease risks

Comprehensive cell surface proteomics defines markers of classical, intermediate and non-classical monocytes

A Method for Identification and Analysis of Non-Overlapping Myeloid Immunophenotypes in Humans

A Meta-Analysis of Immune-Cell Fractions at High Resolution Reveals Novel Associations with Common Phenotypes and Health Outcomes

Using High-Dimensional Approaches to Probe Monocytes and Macrophages in Cardiovascular Disease

Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood

Phenotype, function, and differentiation potential of human monocyte subsets

Mass Spectrometry Based Proteomics Profiling of Human Monocytes

Morphological single-cell analysis of peripheral blood mononuclear cells from 390 healthy blood donors with Blood Cell Painting

Discrepant Phenotyping of Monocytes Based on CX3CR1 and CCR2 Using Fluorescent Reporters and Antibodies

P120 A novel population of classical monocytes is expanded in CD and defined by an upregulation of genes relating to mononuclear cell differentiation and response to microbes

Characterization of CD34+ Cells from Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Using a t-Distributed Stochastic Neighbor Embedding (t-SNE) Protocol